GRACEcast
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
Visit Show Website http://cancerGRACE.org/Recently Aired
-
HD
Dr. Rosalyn Juergens on "My Approach to Maintenance Therapy for Advanced NSCLC"
Dr. Rosalyn Juergens, McMaster University, discusses the evidence and her ...
Dr. Rosalyn Juergens, McMaster University, discusses the evidence and her personal interpretation and recommended approach to maintenance therapy for advanced non-small cell lung cancer.
-
HD
Dr. Sarah Goldberg on "Which patients do you send molecular marker testing for?"
Dr. Sarah Goldberg from Yale Cancer Center describes which patients ...
Dr. Sarah Goldberg from Yale Cancer Center describes which patients with advanced NSCLC she seeks molecular marker testing on.
-
HD
Dr. Ravi Salgia: What is Your Opinion of Patients and Caregivers Searching the Internet for Information?
Dr. Ravi Salgia from the University of Chicago discusses the ...
Dr. Ravi Salgia from the University of Chicago discusses the trend of patients consulting Dr.Google - finding information of varied quality on the internet.
-
HD
Dr. Antoinette Wozniak on Small Cell Lung Cancer: Introduction, Diagnosis, and Staging (video)
Dr. Antoinette (Toni) Wozniak from Karmanos Cancer Center in Detroit, ...
Dr. Antoinette (Toni) Wozniak from Karmanos Cancer Center in Detroit, MI reviews the impact, causes, common symptoms, and approach to staging of small cell lung cancer.
-
HD
Dr. Antoinette Wozniak on Small Cell Lung Cancer: Introduction, Diagnosis, and Staging (audio)
Dr. Antoinette (Toni) Wozniak from Karmanos Cancer Center in Detroit, ...
Dr. Antoinette (Toni) Wozniak from Karmanos Cancer Center in Detroit, MI reviews the impact, causes, common symptoms, and approach to staging of small cell lung cancer.
-
HD
Dr. David Spigel: Will New Forms of Mutation Testing Become Available Beyond the Major Research Centers?
Dr. David Spigel, Sarah Cannon Cancer Center, gives his view ...
Dr. David Spigel, Sarah Cannon Cancer Center, gives his view on more widespread availability of new mutation tests.
-
HD
Dr. Heather Wakelee: Will Our Gains in Targeted Therapies Be Generalizable to a Wider Range of Lung Cancers?
Dr. Heather Wakelee, from Stanford University, provides her perspective on ...
Dr. Heather Wakelee, from Stanford University, provides her perspective on the likelihood that molecular oncology principles and targeted therapies will become more broadly applicable for patients with squamous and other lung cancer subtypes.
-
HD
Dr. Sumanta (Monty) Pal: What Are the Main Types of Kidney Cancer and Are They Managed Differently?
Dr. Sumanta (Monty) Pal, medical oncologist at City of Hope ...
Dr. Sumanta (Monty) Pal, medical oncologist at City of Hope Cancer Center in Duarte, CA, describes the main types of kidney cancer and discusses the differences in their management
-
HD
Dr. Greg Riely: My Approach to Repeat Biopsies For Advanced NSCLC Patients Who Have Insufficient Tissue for Molecular Testing
Dr. Greg Riely, from Memorial Sloan-Kettering, expresses his practice pattern ...
Dr. Greg Riely, from Memorial Sloan-Kettering, expresses his practice pattern for patients with advanced non-small cell lung cancer who would need a repeat biopsy to obtain sufficient tissue to perform molecular marker testing.
-
HD
Dr. Phil Bonomi: How Should We Manage Acquired Resistance with a Single Lesion or More Diffuse Progression?
Dr. Phil Bonomi, from Rush University, offers his insights on ...
Dr. Phil Bonomi, from Rush University, offers his insights on how to approach a patient with gradual progression in a single site, especially in the brain, or more multifocal progression after a good initial response to a targeted agent.
